Osteoarthritis Trial, Recruiting NCT03304730 Sponsor: Hospital Israelita Albert Einstein Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT03304730
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be older than 18 years old
  • You must speak Portuguese fluently or as your native language
  • You must have had low back pain (either constant or coming and going) for at least three months
  • Your back pain may or may not spread to your buttocks, and is made worse by bending backwards or to the side, sitting for long periods, climbing stairs, or staying in one position for a long time — suggesting a specific type of back condition called facet syndrome
  • Standard treatments such as physical therapy or pain medications have not worked well enough for you
  • You must be able to understand what the study is about
  • You must be willing to sign a consent form and fill out questionnaires before and after treatment, either by phone or online

Who may not be able to join:

  • You are under 18 years old
  • You have a narrowing of the spinal canal that causes leg pain or weakness when walking (confirm with trial site)
  • You have nerve pain that travels down your leg from your spine (confirm with trial site)
  • You have an active rheumatological disease, such as rheumatoid arthritis or lupus
  • You have a spine deformity that you were born with or developed over time (confirm with trial site)
  • You have had a fracture of the lower spine, whether from an injury, illness, or brittle bones
  • You have had surgery on your lower spine
  • Your MRI scan images are poor quality or incomplete
  • You have taken steroid tablets or injections throughout your whole body within the last month
  • You have received a steroid injection into your spine joints within the last six months
  • You have diabetes that is not well controlled
  • You have a known allergy to anaesthetics or have had a bad reaction to steroids in the past
  • You are pregnant or currently breastfeeding
  • You would not be reachable by phone during the follow-up period after treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hospital Israelita Albert Einstein
Registry
ClinicalTrials.gov
Start date
1 September 2017
Est. completion
1 December 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Change in Roland Moris Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov